Cloretazine

DRUG2 trials

Sponsors

Northwestern University, M.D. Anderson Cancer Center

Conditions

Brain and Central Nervous System TumorsHematologic Malignancies

Phase 1

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

TerminatedNCT00516282

Northwestern UniversityBrain and Central Nervous System Tumors

Start: 2007-08-31End: 2009-10-31Updated: 2011-08-26

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

CompletedNCT00521859

M.D. Anderson Cancer CenterHematologic Malignancies

Start: 2007-08-31End: 2010-12-31Updated: 2012-07-31